163 related articles for article (PubMed ID: 17113196)
1. Cyclophane and acyclic cyclophane: novel channel blockers of N-methyl-D-aspartate receptor.
Masuko T; Nagaoka H; Miyake M; Metori K; Kizawa Y; Kashiwagi K; Igarashi K; Kusama T
Neurochem Int; 2007 Jan; 50(2):443-9. PubMed ID: 17113196
[TBL] [Abstract][Full Text] [Related]
2. Monoamines directly inhibit N-methyl-D-aspartate receptors expressed in Xenopus oocytes in a voltage-dependent manner.
Masuko T; Suzuki I; Kizawa Y; Kusama-Eguchi K; Watanabe K; Kashiwagi K; Igarashi K; Kusama T
Neurosci Lett; 2004 Nov; 371(1):30-3. PubMed ID: 15500961
[TBL] [Abstract][Full Text] [Related]
3. Anthraquinone polyamines: novel channel blockers to study N-methyl-D-aspartate receptors.
Kashiwagi K; Tanaka I; Tamura M; Sugiyama H; Okawara T; Otsuka M; Sabado TN; Williams K; Igarashi K
J Pharmacol Exp Ther; 2004 Jun; 309(3):884-93. PubMed ID: 14764657
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
Masuko T; Namiki R; Nemoto Y; Miyake M; Kizawa Y; Suzuki T; Kashiwagi K; Igarashi K; Kusama T
J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
[TBL] [Abstract][Full Text] [Related]
5. Cleft-type cyclophanes confer neuroprotection against excitatory neurotoxicity in vitro and in vivo through inhibition of NMDA receptors.
Masuko T; Nemoto Y; Nagaoka H; Miyake M; Kizawa Y; Kusama-Eguchi K; Kashiwagi K; Igarashi K; Kusama T
Neuropharmacology; 2007 Sep; 53(4):515-23. PubMed ID: 17681353
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of linear and cyclic polyamines on NMDA receptor activities.
Masuko T; Miyake M; Kusama-Eguchi K; Koike T; Kimura E; Kizawa Y; Kashiwagi K; Igarashi K; Kusama T
Neurochem Int; 2008 Jul; 53(1-2):38-44. PubMed ID: 18556092
[TBL] [Abstract][Full Text] [Related]
7. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
Williams K
Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753
[TBL] [Abstract][Full Text] [Related]
8. Benzyl-polyamines: novel, potent N-methyl-D-aspartate receptor antagonists.
Igarashi K; Shirahata A; Pahk AJ; Kashiwagi K; Williams K
J Pharmacol Exp Ther; 1997 Nov; 283(2):533-40. PubMed ID: 9353367
[TBL] [Abstract][Full Text] [Related]
9. An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons.
Kashiwagi K; Fukuchi J; Chao J; Igarashi K; Williams K
Mol Pharmacol; 1996 Jun; 49(6):1131-41. PubMed ID: 8649353
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of delta2 glutamate receptors: effects of pentamidine and protons.
Williams K; Dattilo M; Sabado TN; Kashiwagi K; Igarashi K
J Pharmacol Exp Ther; 2003 May; 305(2):740-8. PubMed ID: 12606689
[TBL] [Abstract][Full Text] [Related]
11. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
Frizelle PA; Chen PE; Wyllie DJ
Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
[TBL] [Abstract][Full Text] [Related]
12. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
[TBL] [Abstract][Full Text] [Related]
13. Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine.
Williams K
Mol Pharmacol; 1994 Sep; 46(3):531-41. PubMed ID: 7935335
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of NMDA receptors by butanesulfonyl-homospermine guanidine and neuroprotective effects in in vitro and in vivo.
Masuko T; Suzuki T; Miyake M; Kusama-Eguchi K; Kizawa Y; Tomono K; Kashiwagi K; Igarashi K; Kusama T
Neurosci Lett; 2012 Jan; 506(2):251-5. PubMed ID: 22119002
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of a novel water-soluble cleft-type cyclophane as an N-methyl-D-aspartate receptor antagonist.
Masuko T; Kusama T; Namiki R; Metori K; Kizawa Y; Miyake M
Chem Pharm Bull (Tokyo); 2009 Jan; 57(1):95-8. PubMed ID: 19122326
[TBL] [Abstract][Full Text] [Related]
16. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.
Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ
Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381
[TBL] [Abstract][Full Text] [Related]
17. Single channel analysis of a novel NMDA channel from Xenopus oocytes expressing recombinant NR1a, NR2A and NR2D subunits.
Cheffings CM; Colquhoun D
J Physiol; 2000 Aug; 526 Pt 3():481-91. PubMed ID: 10922001
[TBL] [Abstract][Full Text] [Related]
18. The selectivity filter of the N-methyl-D-aspartate receptor: a tryptophan residue controls block and permeation of Mg2+.
Williams K; Pahk AJ; Kashiwagi K; Masuko T; Nguyen ND; Igarashi K
Mol Pharmacol; 1998 May; 53(5):933-41. PubMed ID: 9584221
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus.
White HS; McCabe RT; Armstrong H; Donevan SD; Cruz LJ; Abogadie FC; Torres J; Rivier JE; Paarmann I; Hollmann M; Olivera BM
J Pharmacol Exp Ther; 2000 Jan; 292(1):425-32. PubMed ID: 10604979
[TBL] [Abstract][Full Text] [Related]
20. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits.
Chatterton JE; Awobuluyi M; Premkumar LS; Takahashi H; Talantova M; Shin Y; Cui J; Tu S; Sevarino KA; Nakanishi N; Tong G; Lipton SA; Zhang D
Nature; 2002 Feb; 415(6873):793-8. PubMed ID: 11823786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
